Three U.S. Bank small business clients among winners of Sacramento SBA[...]
Shattuck Labs to Present at H.C. Wainwright BioConnect 2021 Conference
Shattuck Labs Announces Participation in Citi’s 2021 Virtual[...]
05/01/2024 | Press release | Distributed by Public on 05/02/2024 04:11
UNITED STATES | |
SECURITIES AND EXCHANGE COMMISSION | |
Washington, D.C. 20549 | |
Notice of Effectiveness | |
Effectiveness Date: | May 1, 2024 2:00 P.M. |
Form: | S-1 | |||||
|
Please select the service you want to use:
Smartlinks | AIM ImmunoTech Inc. | News | Health | Company News | Investment Funds | Securities Issuers | Biotechnology and Medical Research Companies | London Stock Exchange (LSE) | New York Stock Exchange (NYSE) | Frankfurt Stock Exchange | Berlin Stock Exchange | Dusseldorf Stock Exchange | Munich Stock Exchange | Stuttgart Stock Exchange | Tradegate Exchange | NYSE American | NYSE ARCA Equities | Cboe BZX Exchange | Cboe BYX Exchange | Cboe EDGA Exchange | Cboe EDGX Exchange | NYSE National | FINRA Alternative Display Facility (ADF) | Investors Exchange (IEX) | Nasdaq BX | Nasdaq Intermarket | Nasdaq PSX | NYSE Chicago
Copyright ©2006-2024 Public Technologies Inc. | Privacy Policy | Terms of Use | Contact